Tablets - 5 mg

Glibenklamid is an oral hypoglycemiant, derivative of the sulfonylurea. The decrease of blood glucose concentration happens because of the stimulation of insulin secretion by the pancreas. This action needs the presence of the beta functional cells.

Glibenklamid is indicated in diabetes mellitus type II (non-insulin dependent diabetes) that does not respond to strict diet, weight loss (for overweight patients) and exercise.